Dr. Mark Yarchoan is an oncologist in Baltimore, caring for patients with gastrointestinal cancers. His clinical focus is on cancers of the liver, including hepatocellular carcinoma and biliary tract cancer (cholangiocarcinoma).

He directs a National Cancer Institute funded laboratory focused on the discovery of novel cancer immunotherapies for hepatobiliary cancers.

Dr. Yarchoan co-leads the Liver Cancer Multidisciplinary Clinic. He has been recognized with an ASCO Young Investigator Award, and the Director’s Teaching Award in Clinical Science, the Cholangiocarcinoma Foundation’s Mark R. Clements Award, and a Conquer Cancer Foundation/ASCO Career Development Award.